DesiNew – Daily Breaking News and Updates

Six Kovid-19 vaccines currently undergoing clinical trials in India – India news

Stating that the Drugs Controller General of India has approved for clinical trials of another candidate vaccine from India, Dr. NITI Aayog member (Health) Dr. VK Paul said on Tuesday that six vaccines are currently undergoing clinical trials in the country.

“This week, the Drugs Controller General of India approved another clinical trial for the vaccine of another candidate from India. The Genoa company has developed a vaccine in collaboration with the Department of Biotechnology, the research agency of the Government of India, ”Dr. Paul said while addressing a press conference here.

He said that the technology used in it is similar to the Pfizer vaccine.

“Unlike the Pfizer vaccine or something else, this vaccine – if it comes into existence – would be able to be maintained in normal cold chain conditions, in a common refrigerator. At the moment, six vaccines are undergoing clinical trials in this country, ”said Dr. Paul.

The member of NITI Aayog also expressed concern over the Kovid-19 spread amid protests by farmers running along the borders of the national capital. “We should be careful, messages have been sent to them (to farmers) from the government. The democracy process should continue but we should also follow the Kovid-19 guidelines.

Dr. Paul said that recently condemning the spike reduction states and union territories in the Kovid-19 cases, he said that they are happy that Delhi has made progress.

“We congratulate the Delhi government as well as other governments that have contributed in recent times to such significant control. There are states where we still have concerns. We request the government and citizens of Uttarakhand, Nagaland and Himachal Pradesh to do everything possible to bring the situation under control, ”said Paul.

Addressing the press conference, Secretary of the Ministry of Health and Family Welfare Rajesh Bhushan said that India has the lowest number of cases per million population in the world.

“29,000 cold chain points, 240 walk-in coolers, 70 walk-in freezers, 45000 ice-lined refrigerators, 41,000 deep freezers and 300 solar refrigerators will be used. All these devices have reached the state governments, ”Bhushan said.

He said that the number of COVID-19 cases in India is 7,178 per million population as against the global average of 9,000. He also expressed concern over the adverse effects of vaccination and suggested the States and Union Territories to prepare for the same.

“Adverse events after vaccination are an important issue. When we do a universal immunization program, which has been done for decades, some adverse effects are seen in children and pregnant women after vaccination, ”Bhushan said.

“So, we cannot rule out the possibility of an adverse event when Kovid vaccination begins. In countries where vaccination has already started, especially in the UK, adverse events occurred on the first day. Therefore, it is necessary. That states and union territories should be ready for this as well, ”he said.

The Ministry of Health and Family Welfare said today that it reached a total of 99,06,165 Kovid-19 cases in India with 22,065 new cases and 254 new deaths. A total of 1,43,709 people have died due to the virus so far.


Exit mobile version